WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today named Gregory C. Critchfield, M.D., M.S., to its board of directors, adding his expertise in disease testing and pharmaceutical development to the BioTrove board. Dr. Critchfield, current president of Myriad Genetic Laboratories, Inc., a wholly owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN), expands the BioTrove board to seven corporate directors.
